These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


165 related items for PubMed ID: 23056374

  • 1. XZH-5 inhibits STAT3 phosphorylation and enhances the cytotoxicity of chemotherapeutic drugs in human breast and pancreatic cancer cells.
    Liu A, Liu Y, Jin Z, Hu Q, Lin L, Jou D, Yang J, Xu Z, Wang H, Li C, Lin J.
    PLoS One; 2012; 7(10):e46624. PubMed ID: 23056374
    [Abstract] [Full Text] [Related]

  • 2. Novel small molecule, XZH-5, inhibits constitutive and interleukin-6-induced STAT3 phosphorylation in human rhabdomyosarcoma cells.
    Liu A, Liu Y, Xu Z, Yu W, Wang H, Li C, Lin J.
    Cancer Sci; 2011 Jul; 102(7):1381-7. PubMed ID: 21435102
    [Abstract] [Full Text] [Related]

  • 3. A novel small molecule, LLL12, inhibits STAT3 phosphorylation and activities and exhibits potent growth-suppressive activity in human cancer cells.
    Lin L, Hutzen B, Li PK, Ball S, Zuo M, DeAngelis S, Foust E, Sobo M, Friedman L, Bhasin D, Cen L, Li C, Lin J.
    Neoplasia; 2010 Jan; 12(1):39-50. PubMed ID: 20072652
    [Abstract] [Full Text] [Related]

  • 4. XZH-5 inhibits STAT3 phosphorylation and causes apoptosis in human hepatocellular carcinoma cells.
    Liu Y, Liu A, Xu Z, Yu W, Wang H, Li C, Lin J.
    Apoptosis; 2011 May; 16(5):502-10. PubMed ID: 21311975
    [Abstract] [Full Text] [Related]

  • 5. A novel small molecular STAT3 inhibitor, LY5, inhibits cell viability, cell migration, and angiogenesis in medulloblastoma cells.
    Xiao H, Bid HK, Jou D, Wu X, Yu W, Li C, Houghton PJ, Lin J.
    J Biol Chem; 2015 Feb 06; 290(6):3418-29. PubMed ID: 25313399
    [Abstract] [Full Text] [Related]

  • 6. Design, synthesis and evaluation of XZH-5 analogues as STAT3 inhibitors.
    Daka P, Liu A, Karunaratne C, Csatary E, Williams C, Xiao H, Lin J, Xu Z, Page RC, Wang H.
    Bioorg Med Chem; 2015 Mar 15; 23(6):1348-55. PubMed ID: 25698618
    [Abstract] [Full Text] [Related]

  • 7. Cryptotanshinone inhibits constitutive signal transducer and activator of transcription 3 function through blocking the dimerization in DU145 prostate cancer cells.
    Shin DS, Kim HN, Shin KD, Yoon YJ, Kim SJ, Han DC, Kwon BM.
    Cancer Res; 2009 Jan 01; 69(1):193-202. PubMed ID: 19118003
    [Abstract] [Full Text] [Related]

  • 8. Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.
    Yang F, Brown C, Buettner R, Hedvat M, Starr R, Scuto A, Schroeder A, Jensen M, Jove R.
    Mol Cancer Ther; 2010 Apr 01; 9(4):953-62. PubMed ID: 20371721
    [Abstract] [Full Text] [Related]

  • 9. Stat3 activation in human endometrial and cervical cancers.
    Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J.
    Br J Cancer; 2007 Feb 26; 96(4):591-9. PubMed ID: 17311011
    [Abstract] [Full Text] [Related]

  • 10. B7-H3 silencing increases paclitaxel sensitivity by abrogating Jak2/Stat3 phosphorylation.
    Liu H, Tekle C, Chen YW, Kristian A, Zhao Y, Zhou M, Liu Z, Ding Y, Wang B, Mælandsmo GM, Nesland JM, Fodstad O, Tan M.
    Mol Cancer Ther; 2011 Jun 26; 10(6):960-71. PubMed ID: 21518725
    [Abstract] [Full Text] [Related]

  • 11. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Yao X, Zhu F, Zhao Z, Liu C, Luo L, Yin Z.
    J Cell Biochem; 2011 Oct 26; 112(10):2837-49. PubMed ID: 21608020
    [Abstract] [Full Text] [Related]

  • 12. Novel STAT3 phosphorylation inhibitors exhibit potent growth-suppressive activity in pancreatic and breast cancer cells.
    Lin L, Hutzen B, Zuo M, Ball S, Deangelis S, Foust E, Pandit B, Ihnat MA, Shenoy SS, Kulp S, Li PK, Li C, Fuchs J, Lin J.
    Cancer Res; 2010 Mar 15; 70(6):2445-54. PubMed ID: 20215512
    [Abstract] [Full Text] [Related]

  • 13. Downregulation of STAT3 signaling induces apoptosis but also promotes anti-apoptotic gene expression in human pancreatic cancer cell lines.
    Glienke W, Hausmann E, Bergmann L.
    Tumour Biol; 2011 Jun 15; 32(3):493-500. PubMed ID: 21174186
    [Abstract] [Full Text] [Related]

  • 14. Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells.
    Huang S, Sinicrope FA.
    Mol Cancer Ther; 2010 Mar 15; 9(3):742-50. PubMed ID: 20197401
    [Abstract] [Full Text] [Related]

  • 15. Capsaicin is a novel blocker of constitutive and interleukin-6-inducible STAT3 activation.
    Bhutani M, Pathak AK, Nair AS, Kunnumakkara AB, Guha S, Sethi G, Aggarwal BB.
    Clin Cancer Res; 2007 May 15; 13(10):3024-32. PubMed ID: 17505005
    [Abstract] [Full Text] [Related]

  • 16. Benzyl isothiocyanate inhibits oncogenic actions of leptin in human breast cancer cells by suppressing activation of signal transducer and activator of transcription 3.
    Kim SH, Nagalingam A, Saxena NK, Singh SV, Sharma D.
    Carcinogenesis; 2011 Mar 15; 32(3):359-67. PubMed ID: 21163886
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of potential Stat3-regulated genes in human breast cancer.
    Hsieh FC, Cheng G, Lin J.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048
    [Abstract] [Full Text] [Related]

  • 18. JAK2 regulation by licochalcone H inhibits the cell growth and induces apoptosis in oral squamous cell carcinoma.
    Oh HN, Oh KB, Lee MH, Seo JH, Kim E, Yoon G, Cho SS, Cho YS, Choi HW, Chae JI, Shim JH.
    Phytomedicine; 2019 Jan 23; 52():60-69. PubMed ID: 30599913
    [Abstract] [Full Text] [Related]

  • 19. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB.
    Zhang Y, Bharadwaj U, Logsdon CD, Chen C, Yao Q, Li M.
    Clin Cancer Res; 2010 Mar 01; 16(5):1423-30. PubMed ID: 20160059
    [Abstract] [Full Text] [Related]

  • 20. Plumbagin, a plant derived natural agent inhibits the growth of pancreatic cancer cells in in vitro and in vivo via targeting EGFR, Stat3 and NF-κB signaling pathways.
    Hafeez BB, Jamal MS, Fischer JW, Mustafa A, Verma AK.
    Int J Cancer; 2012 Nov 01; 131(9):2175-86. PubMed ID: 22322442
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.